Sitemap - 2022 - The California Stem Cell Report
Holiday Break for California Stem Cell Report
Bubble Babies, UCLA and the California Stem Cell Agency: What's Next?
Text of Statement from SCID Angels for Life on Resumption of UCLA Bubble Baby Trial
'He Lifted Us Up:' CIRM Mourns Loss of Patient Advocate Leader and Spokesman
Gov. Newsom Chides State Stem Cell Agency Re Election of a New Chair for the $12 Billion Program
California 'Dreaming:' Edit a Gene, Stave off Death for Millions Globally
CIRM Scrubs Election Next Week for New Chair after Nominee John Perez Pulls Out
The 'Best Christmas Gift:' Once Abandoned Clinical Trial for Bubble Babies Wins Regulator Go Ahead
California Stem Cell Agency Awards $41 Million For Clinical Trials and Translational Research
Tracking the CIRM: California Plans $83 Million for Community Centers for Cell and Gene Therapy
Tracking the CIRM: $41 Million in Awards Upcoming, Plus Opportunities for More
Quote of the Day: Altos Labs, Bezos and Rejuvenation
Looking for Work? California's Stem Cell Program has Five Interesting Openings
Scientific Skinflints, Post-doc Salaries and What it Means for the Future of Science
From Alpha Clinics to Melanoma, California's Stem Cell Agency Chalks Up a $137 Million Day
Tracking the CIRM: Travel Ban to 23 States, Annual Review of CIRM Finances
A Look Back: Tenuous Oversight of the $12 Billion California Stem Cell and Gene Therapy Agency
Offline but Coming Back Next Week with a Look at a $137 Million Day
Tracking the CIRM: $129 Million Meeting this Thursday, New Chair and Opportunities to Weigh In
Public Can Weigh In Next Week on Candidates for New Chair of $12 Billion California Stem Cell Agency
$64 Million Slated for California's Alpha Stem Cell Clinic Program; One Application Rejected
$12 Billion, California Stem Agency Looking to Fill Eight Slots
Health Justice, Multimillion Dollar Treatments and California's Stem Cell and Gene Therapy Agency
California's Great Stem Cell Experiment: A Look Inside the $12 Billion, State Stem Cell Agency
Tracking the CIRM: $50 Million Lab Construction Plan Up for Consideration
Salary of New Chair of California's Stem Cell Agency Set at $569K
Bluebird Bio's Not-So-Happy Song and What It Says to the California Stem Cell Agency
Tracking the CIRM: What to Pay the New Chair, Plus Paying Expenses of Patients in Clinical Trials
Top Salary at California Stem Cell Agency Could be $632K
Where Has $3 Billion-Plus Gone?
A Pay and Benefits 'Philosophy' at a $12 Billion California Research Enterprise
Looking for Work? CIRM is Hiring for Top Posts
Two Candidates Named: $12 Billion Stem Cell Agency and the Race for the New Chair
Tracking the CIRM: Millions Slated This Week for Clinical Trial for "Functional Cure" for HIV
Faltering Start to Selection of New Chair for California's $12 Billion Stem Cell Agency
Starting Gun Today for Race for Selection of New Chair for California's $12 Billion Stem Cell Agency
California Stem Cell People: Vuori and Brenner Making Changes
From Roche to Poseida to CIRM: A Small Window on Cell Research and Potential Conflicts of Interest
Tracking the CIRM: $632,000 Salary on Table Monday, Update Also on Search for New CIRM Chair
'Sky No Longer The Limit:' $150 Million to UC San Diego and Stem Cells in Space
'Double Whammy' Therapy for ALS Clears Safety Hurdle in $6 Million California-funded Clinical Trial
Quote of the Day: On 'Zombie' Cells and Never Having to Write Another Grant
Tracking the CIRM: $46 Million Slated to be Handed Out Tuesday Morning
California Stem Cell Agency Upfront with Conflict of Interest Information
Call it IRP: New California Effort to Engage Stem Cell Research with Industry
Tracking the CIRM: A Sleepy August at Least Publicly
A Child 'Punished for Not Being Profitable...' -- A Mother's Comment
"The Great Abandonment:" Gene Therapy, California's Stem Cell Agency, Profit vs. Cures
Searching for Profits Stymies Gene Therapies: A California Perspective on an International Problem
Evangelina's Excellent Decade: An Update on a Case of the Bubble Baby Disease and a Gene Therapy
$80 Million in California to Smash Bottlenecks to Manufacturing Cell and Gene Therapies
The Golden State's Stem Cell Story: It is a $49,000 an hour tale
Tracking the CIRM: The Hypersensitive Issue of Salaries is Coming Up This Month
Disappointment and California's Bubble Baby Saga: Some CIRM Directors Look to Avoid a Repetition
California's Stem Cell Trial for Life-Threatening Bubble Baby Disease Stalled Again
CIRM Hands Out $25 Million for Basic Research into Host of Diseases
Financial Assistance for California Stem Cell Patients, Self-Dealing and the Need for Clean Skirts
Royalty Language Cracks Firewall Between Lawmakers and $12 Billion California Stem Cell Agency
Text of Royalty Use Language from Proposition 14 of 2020
A Tale of How Patient Power in California Helped to Move a Stem Cell Treatment Forward
Tracking the CIRM: Job Postings, Looming Budget Matters, Progress on New Data Sharing Network
Irony, Conflicts of Interest and Multimillion Dollar California Research Awards
Tracking the CIRM: $419 Million in Awards to be Budgeted, Selection of New Chair Update
California Stem Cell Agency Chalks Up 80 Clinical Trials
Tracking the CIRM: Problem with Earlier Award, $19 Million More to be Awarded
LA Times Reports Death of Leading Figure in the Unregulated Stem Cell Industry
Deploying $15.6 Million for Patient Assistance in Cell and Gene Therapy Trials...But Not Tomorrow
Tracking the CIRM: Salary for its Chair, Financial Aid for Patients
California's Stem Cell Program is Back Online with Its Website and E-mail
Update: California Stem Cell Internet Outage Enters Fifth Day
California Stem Cell Program Still in the Dark on the Internet
Website for California's $12 Billion Cell and Gene Therapy Program is Offline
A Look Back: Why California's Stem Cell Royalties are Relatively Skimpy
$90 Million Left on the California Cell and Gene Therapy Table
The Shameless Stem Cell Business: Blogs, Tweets and Lists
California Plans to Spend a Fresh $427 Million for Stem Cell and Gene Therapy Research
California Stem Cell Finances: A Tale of Delay and 'Helpful' Oversight
Tracking the CIRM: A $26 Million Operations Budget, 44 Percent Boost From the Current Year
California Pops for $26 Million to Fight Afflictions Ranging from Prostate Cancer to Eye Disease
Looking for Work? California's Stem Cell Program Plans to Hire 10 Persons Beginning in July
Altos Labs & CIRM: Synergies, Supplicants and Cell Therapy?
Another Chapter in the California Story of a 'Don't Eat Me Signal' and $4.9 Billion
California's Stem Cell Agency to Stage First In-Person Meeting in Two Years
Gene Therapy Drubbings: What Does it Mean for California's $12 Billion Research Effort?
Tracking the $12 Billion California Stem Cell Program
California Expands Investments into New Areas of Gene Therapy, Including mRNA
Text of the Scope of Gene Therapy that Can Be Financed by the California Stem Cell Agency
Fifty Stem Cell 'Influencers' and 'Tweeter' Brought to You by a California 'Tweeter' Himself
Tracking the $12 Billion California Stem Cell Program
Choosing a Chair: California Stem Cell Agency Looking for Candidate to Help it Stay Alive
A First in California for Gene and Cell Therapy Research
CIRM Boosts its Score on the California Sunshine Index
CIRM's New Chair Challenge: Directors Inched Ahead Today, Hoping to Fill Slot by January
Critical Issues Facing the CIRM 35: A New Chair Challenge and a Sticky Dual Executive History
Quote of the Day: On Crawling Under a Couch
Shades of 2010? Tardiness, Transparency and Trust and the California Stem Cell Agency
Golden State's Stem Cell Program to Replace Current Chair: A Trail Guide to the Unusual Process
The Dual Executive Language Involving the California Stem Cell Agency
A Reading List on the Last Election of a Chairman of California's Stem Cell Agency
Text of State Law re CIRM Chair Selection Process and Criteria for Candidates
California's Stem Cell Agency Fills VP Medical Affairs Post with Matanzas President
Looking Back: The Last and Only Contested Race for Chair of the California Stem Cell Agency
The California Stem Cell Report Has Moved
$20 Million California Plan Targets Critical Gaps Hampering Cell and Gene Therapies
More than 100 CRISPR Patents 'Wiped Off the Face of the Earth'
It's a Tale of Ticking Clocks and Risky Endeavors
Tracking the California Stem Cell Agency from New Award Plans to Speeches
California's Bubble Baby Cure: 'Much More Work to Do'
Fifty-four-year-old California Stem Cell Researcher Takes on 171-year-old Gray Lady
Good News for the Bubble Baby Disease Treatment Backed by Millions from California Taxpayers
California Governor Names Two to Board of $12 Billion California Stem Cell Agency
Four Job Opportunities at California's $12 Billion Stem Cell Agency
Making Multi-Million Dollar Therapies Affordable: California Edges Forward on Its Effort
California's Stem Cell Agency Collects First Major Royalties: $15.6 Million from Stanford
$3 Billion 'Cellular Rejuvenation' Firm in California Greeted with Snark and Awe
Text of CIRM's Data Sharing Requirements for Alpha Clinic Applicants
Performance Audit Finding: The California Stem Cell Agency's "Unmention' Problem Needs to be Fixed
New VP for Medical Affairs Sought by $12 Billion Golden State Cell and Gene Therapy Program
'Taking Things Too Far,' Stem Cells, Hype and Ballot Campaigns
A $28 Million 'Unmention' in the University of California's Top Research Story of the Year
Bubble Baby Gene Therapy and Orchard Therapeutics: Tangled Tale Dominates Reader Interest